• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心脏停搏液和钙通道阻滞剂对冠状动脉收缩的影响]

[Effects of cardioplegic solution and calcium entry blockers on coronary artery contraction].

作者信息

Yoshida K, Fujii Y, Ina H, Fujioka S, Maseki T, Abe T

机构信息

Department of Surgery, Kiryu Welfare General Hospital, Japan.

出版信息

Nihon Kyobu Geka Gakkai Zasshi. 1990 Jan;38(1):86-92.

PMID:2329309
Abstract

We studied the effects of the electrolyte composition (K, Ca, Na) and calcium entry blockers of the extracellular fluid on the tension development of isolated canine coronary arterial strips. In 20 mEq/l K solution, 4.7 mEq/l calcium produced coronary artery contraction. This Ca-induced contraction was inhibited dose-dependently by calcium entry blockers-nifedipine, nicardipine, diltiazem and verapamil. In the presence of 20 mEq/l K, the reduction of sodium concentration to 12 mEq/l increased the tension of coronary artery. Calcium entry blockers did not affect this tension development. After 5 or 30 min perfusion of calcium entry blockers, Ca-induced contraction was inhibited. It is concluded that low calcium, high sodium cardioplegic solution or addition of calcium entry blockers may relax the canine coronary artery.

摘要

我们研究了细胞外液的电解质组成(钾、钙、钠)以及钙通道阻滞剂对离体犬冠状动脉条张力发展的影响。在20毫当量/升钾溶液中,4.7毫当量/升钙可引起冠状动脉收缩。这种钙诱导的收缩被钙通道阻滞剂硝苯地平、尼卡地平、地尔硫卓和维拉帕米剂量依赖性地抑制。在存在20毫当量/升钾的情况下,将钠浓度降至12毫当量/升会增加冠状动脉的张力。钙通道阻滞剂不影响这种张力发展。在灌注钙通道阻滞剂5或30分钟后,钙诱导的收缩受到抑制。得出的结论是,低钙、高钠心脏停搏液或添加钙通道阻滞剂可能会使犬冠状动脉松弛。

相似文献

1
[Effects of cardioplegic solution and calcium entry blockers on coronary artery contraction].[心脏停搏液和钙通道阻滞剂对冠状动脉收缩的影响]
Nihon Kyobu Geka Gakkai Zasshi. 1990 Jan;38(1):86-92.
2
[Effects of electrolyte composition and temperature of extra-cellular fluid on coronary artery contraction].[细胞外液的电解质组成和温度对冠状动脉收缩的影响]
Nihon Geka Gakkai Zasshi. 1989 Feb;90(2):291-7.
3
Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.地尔硫䓬、尼卡地平、硝苯地平和维拉帕米在无钙培养基中对去甲肾上腺素诱导的犬隐静脉收缩的抑制作用。
Res Commun Chem Pathol Pharmacol. 1994 Mar;83(3):255-69.
4
The effects of calcium antagonists and prostaglandin E1 on isolated canine coronary arterial tension.钙拮抗剂和前列腺素E1对离体犬冠状动脉张力的影响。
Surg Today. 1994;24(12):1073-7. doi: 10.1007/BF01367458.
5
Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities.用于治疗冠状动脉痉挛的钙通道阻滞剂:理论依据、作用及护理职责
Heart Lung. 1983 May;12(3):226-32.
6
New approaches to prevention and treatment of radial artery graft vasospasm.桡动脉移植血管痉挛预防与治疗的新方法。
Circulation. 1998 Nov 10;98(19 Suppl):II15-21; discussion II21-2.
7
Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.新型钙拮抗剂(±)-(E)-1-(3-氟-6,11-二氢二苯并[b,e]氧杂卓-11-基)-4-(3-苯基-2-丙烯基)-哌嗪二马来酸盐在兔和犬离体脑动脉中的脑血管选择性及血管痉挛解作用
Arzneimittelforschung. 1997 Apr;47(4):339-46.
8
Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.地尔硫䓬、硝苯地平及维拉帕米的变时性、变力性和血管舒张作用。生理反应与膜受体活性的比较研究。
Circ Res. 1983 Feb;52(2 Pt 2):I29-39.
9
[Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].[尼卡地平对多次剂量钾停搏液灌注的缺血大鼠心脏的功能和代谢影响]
Nihon Kyobu Geka Gakkai Zasshi. 1990 Apr;38(4):630-40.
10
Clinical use of calcium entry blockers.
Fed Proc. 1981 Dec;40(14):2877-81.